• Home
  • Search Results

Search Results

374 studies match your search
Open

CAR T-Cells Targeting the GD2 Antigen for Relapsed/Refractory Neuroblastoma orRelapsed/Refractory Neuroblastoma and Osteosarcoma

Do you have Neuroblastoma or Osteosarcoma that has either come back or did not get better with your last treatment? If so, you may be able to take part in a study that will modify your own immune cells to see if it may treat your cancer.

Age & Gender
  • 0 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Brain and Other Nervous System, Sarcoma (bone and soft tissue))
Open

Relapsed/Refractory B-cell Lymphoma Study

Have you been diagnosed with B-Cell Lymphoma? Are you looking for options to treat your cancer? If so, you may be able to take part in a research study looking at the safety of giving a new drug called iC9-CAR19 with Rimiducid.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

SALTY - Asthma Study

Do you require daily medication to keep your asthma controlled? We are doing a research study to see if inhaling saltwater that is stronger than what is normally in your body will help clear mucus.

Age & Gender
  • 18 years ~ 60 years
  • Male, Female
Study Interest
  • Lungs and Breathing
Open

Study of BGB-A425 in Combination With Tislelizumab in Advanced Solid Tumors

Do you have histologically or cytologically documented locally advanced or recurrent non-small cell lung cancer (NSCLC) that is not eligible for curative surgery and/or definitive radiotherapy with or without chemoradiotherapy, or metastatic-nonsquamous or squamous NSCLC? If so, you may be eligble to participate in a research study investigating the safety, tolerability, pharmacokinetics and preliminary antitumor activity of various combinations of investigational drugs (BGB A425 and LBL-007) with Tislelizumab.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck, Lung)
Open

Study of ATLCAR.CD138 cells for relapsed/refractory Multiple Myeloma

Have you been diagnosed with Relapsed/Refractory Multiple Myeloma? You may be able to take part in a gene transfer research study that uses your own modified immune cells to see if it is effective in treating your cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Multiple Myeloma)
Open

Study of CAR-T cells in relapsed/refractory Hodgkin's Lymphoma and Cutaneous T-Cell Lymphoma

Do you have Hodgkin's Lymphoma, or Cutaneous T-Cell Lymphoma? Has your lymphoma come back, or did not get better after your last treatment? If so, you might be able to take part in a study that will modify your own immune cells to see if it may treat your lymphoma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

Registry for Adults With Plasma Cell Disorders.

Have you been diagnosed with a plasma cell disorder? You may be able to join a registry to help us learn more about the effects of plasma cell disorders on different aspects of life.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
Open

Ulixertinib/Palbociclib in Patients With Advanced Melanoma

Have you been diagnosed with melanoma? If so, you may be eligible to take part in a research study looking at the safety of giving a combination of drugs called Ulixertinib and Palbociclib to patients with advanced melanoma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Melanoma)
Open

CD19 CAR T-cells containing a Safety Switch to treat Relapsed /Refractoy Acute Lymphoblastic Leukemia

Have you been diagnosed with Acute Lymphoblastic Leukemia? Has your leukemia come back or didn't get better after your last treatment? If so, you may be able to take part in a research study to learn more about the safety of modifying your own immune cells to treat your leukemia.

Age & Gender
  • 3 years ~ 70 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

GDCN Registry

We are looking for patients with kidney disease and healthy controls (no kidney disease) to provide blood samples, fill out surveys, and provide health related information to help investigators learn more about how to better diagnose and treat kidney disease. The information you provide will go into a "library" of data for doctors and researchers across the world to use for research projects. If you are a kidney patient, we are able to use your information to find out if you are eligible for treatment studies/other studies in the future.

Age & Gender
  • 1 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Healthy Volunteer or General Population
  • Urinary and Bladder
  • and 2 more
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research